Chemistry:Zeteletinib
From HandWiki
Short description: Chemical compound
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C25H23F3N4O4 |
| Molar mass | 500.478 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Zeteletinib (BOS-172738, DS-5010) is an experimental anticancer medication which acts as a RET inhibitor.[1][2]
See also
References
- ↑ "RET kinase inhibitors for RET-altered thyroid cancers". Therapeutic Advances in Medical Oncology 14: 17588359221101691. 2022. doi:10.1177/17588359221101691. PMID 35756966.
- ↑ "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland) 27 (24): 8839. December 2022. doi:10.3390/molecules27248839. PMID 36557971.
